MAINZ BIOMED NV (MYNZ)
NL0015000LC2 - Common Stock
ChartMill assigns a Buy % Consensus number of 46% to MYNZ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.04. This target is -69.46% below the current price.
MYNZ was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about MYNZ.
In the last month the buy percentage fell by 34 points. So the trust of analysts is decreasing.
MYNZ was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-25 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-04-12 | Cantor Fitzgerald | Reiterate | Neutral |
| 2024-03-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-21 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-11-20 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-18 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-04-27 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-16 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-10 | JonesTrading | Initiate | Buy |
| 2022-10-25 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-06-21 | HC Wainwright & Co. | Initiate | Buy |